Zymeworks Inc., a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, today announced it has executed a licensing agreement with Janssen Biotech, Inc. (“Janssen”), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The deal was facilitated by Johnson & Johnson Innovation. Under the terms of the licensing agreement, Zymeworks will provide Janssen…
Read More
There has been a recent interest in understanding how a western lifestyle can influence inflammatory disease.  Our study has shed light on the mechanism by which the gut microbiome can influence lung inflammation and highlights specific immunological pathways that are essential in this interaction. We show that gut dysbiosis can exacerbate allergic lung inflammation...
Read More
Peterson’s Lab Inc,. a developer of bioactive recombinant protein, announced that the Company entered into a strategic cooperation with Shanghai Corday Biotech Ltd. under which Shanghai Corday will assume responsibility, on an exclusive basis, for Peterson’s Lab’s brand promotion and branded prestige skin care products to consumers in China, Japan and South Korea. “Shanghai Corday Biotech gives the Company access to three of the…
Read More
The Trudeau government’s decision last month to name a federal science adviser should come as welcome news to anyone who supports principles like evidence-informed policy-making and broader initiatives that support Canada’s research and innovation sectors. The appointment of Dr. Mona Nemer, a distinguished molecular geneticist, comes at a time when Ottawa is preparing to invest $950 million in a network…
Read More
Clinical trials have demonstrated that immediate initiation of antiretroviral therapy (ART) reduces AIDS-related morbidity and mortality. We tested the hypothesis that initiating ART ≤30 days after HIV diagnosis would be associated with reduced mortality among people living with HIV (PLWH) with CD4 counts >500 cells/mm3. METHODS: PLWH enrolled in the Chinese National Free ART Program between January 2012 and June…
Read More

Can a Simple Smartphone App Stop Pneumonia in Its Tracks?

World Pneumonia Day is November 12, 2017. Established in 2009, World Pneumonia Dayaims to raise awareness of the impact that the illness has around the world. Globally, pneumonia is the leading infectious killer of children under the age of five and kills an estimated one million kids each year. Despite being easy to prevent and treat with antibiotics, oxygen and fluids,…
Read More
The state of North Carolina is home for Lumbee Native Americans. Approximately 1 in 5000 people of this population are affected by a severe disorder known as 'Native American Myopathy'.  Patients have severe muscle weakness and developmental defects. The root cause is a mutation in a gene known as 'STAC3'.  In this publication we studied the role of this protein and mapped the location of the genetic mutation on its 3D structure...
Read More
It’s one of the most exciting, and controversial, areas of health science today: new technology that can alter the genetic content of cells, potentially preventing inherited disease — or creating genetically enhanced humans. But Canada is among the few countries in the world where working with the CRISPR gene-editing system on cells whose DNA can be passed down to future…
Read More

Merck & CDRD Announce Joint Investment in the Canadian Life Sciences Ecosystem

The Canadian scientific community gathered in Ottawa this week to engage in a national dialogue on science, technology and innovation policy at the annual Canadian Science Policy Conference. Just prior to the Keynote Address at this event by the Honourable Kirsty Duncan, Minister of Science, Merck Canada Inc. and CDRD – The Centre for Drug Research and Development, announced the…
Read More